Penumbra, Inc. (PEN): Price and Financial Metrics

Penumbra, Inc. (PEN): $205.70

2.70 (+1.33%)

POWR Rating

Component Grades








PEN Price/Volume Stats

Current price $205.70 52-week high $348.67
Prev. close $203.00 52-week low $180.93
Day low $203.10 Volume 391,900
Day high $207.21 Avg. volume 344,024
50-day MA $232.83 Dividend yield N/A
200-day MA $243.97 Market Cap 7.96B

PEN Stock Price Chart Interactive Chart >

Penumbra, Inc. (PEN) Company Bio

Penumbra Inc. is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. The company was founded in 2004 and is based in Alameda, CA.

PEN Latest News Stream

Event/Time News Detail
Loading, please wait...

PEN Latest Social Stream

Loading social stream, please wait...

View Full PEN Social Stream

Latest PEN News From Around the Web

Below are the latest news stories about PENUMBRA INC that investors may wish to consider to help them evaluate PEN as an investment opportunity.

5 MedTech Stocks Poised to Continue Their Winning Streaks in 2024

Stocks like DexCom Inc. (DXCM), Integer Holdings (ITGR), Penumbra (PEN), Haemonetics (HAE), Health Equity (HAE) and are likely to continue their strong performance in 2024.

Yahoo | December 26, 2023

Penumbra (PEN) Stock Up 16.2% YTD: Will the Rally Continue?

Investors are optimistic about Penumbra (PEN), driven by growth in the vascular segments and upbeat guidance.

Yahoo | December 22, 2023

Is Penumbra (PEN) a Good Short Position?

Diamond Hill Capital, an investment management company, released its “Long-Short Fund” third-quarter 2023 investor letter. A copy of the same can be downloaded here. The positive returns of the portfolio outperformed the Russell 1000 Index and the blended benchmark (60% Russell 1000 Index/40% Bloomberg US Treasury Bills 1-3 Month Index), both of which were negative in […]

Yahoo | December 21, 2023

Here's Why You Should Invest in Penumbra (PEN) Stock Now

Investors are optimistic about Penumbra (PEN), which is led by growth in vascular and neuro businesses.

Yahoo | December 19, 2023

Penumbra, Inc. to Present at the J.P. Morgan 42nd Annual Healthcare Conference

Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the J.P. Morgan 42nd Annual Healthcare Conference on Monday, January 8, 2024.

Yahoo | December 19, 2023

Read More 'PEN' Stories Here

PEN Price Returns

1-mo -6.54%
3-mo -17.91%
6-mo 6.69%
1-year -27.80%
3-year -30.91%
5-year 50.10%
YTD -18.22%
2023 13.07%
2022 -22.57%
2021 64.18%
2020 6.53%
2019 34.43%

Continue Researching PEN

Here are a few links from around the web to help you further your research on Penumbra Inc's stock as an investment opportunity:

Penumbra Inc (PEN) Stock Price | Nasdaq
Penumbra Inc (PEN) Stock Quote, History and News - Yahoo Finance
Penumbra Inc (PEN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!